Empowered Funds LLC trimmed its holdings in shares of The Allstate Co. (NYSE:ALL - Free Report) by 78.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,472 shares of the insurance provider's stock after selling 53,899 shares during the period. Empowered Funds LLC's holdings in Allstate were worth $2,790,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. FSA Wealth Management LLC bought a new position in Allstate during the 3rd quarter worth about $26,000. Northwest Investment Counselors LLC bought a new position in Allstate during the 3rd quarter worth about $28,000. Catalyst Capital Advisors LLC bought a new position in Allstate during the 3rd quarter worth about $29,000. Peoples Bank KS bought a new position in Allstate during the 4th quarter worth about $49,000. Finally, Golden State Wealth Management LLC bought a new position in Allstate during the 4th quarter worth about $57,000. 76.47% of the stock is currently owned by institutional investors.
Allstate Stock Performance
ALL stock traded down $5.24 during trading on Monday, reaching $187.53. The company had a trading volume of 3,917,486 shares, compared to its average volume of 1,603,816. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The Allstate Co. has a twelve month low of $153.87 and a twelve month high of $209.88. The firm has a 50-day simple moving average of $190.91 and a 200-day simple moving average of $189.87. The company has a market cap of $49.66 billion, a price-to-earnings ratio of 11.04, a price-to-earnings-growth ratio of 1.47 and a beta of 0.52.
Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. As a group, sell-side analysts expect that The Allstate Co. will post 18.64 earnings per share for the current year.
Insider Buying and Selling at Allstate
In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of Allstate stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.80% of the company's stock.
Analyst Ratings Changes
ALL has been the topic of several recent research reports. Morgan Stanley increased their target price on shares of Allstate from $220.00 to $228.00 and gave the stock an "overweight" rating in a report on Thursday, November 7th. Wells Fargo & Company lifted their price objective on shares of Allstate from $186.00 to $187.00 and gave the stock an "equal weight" rating in a research report on Tuesday, January 14th. UBS Group lifted their price objective on shares of Allstate from $216.00 to $225.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. The Goldman Sachs Group lifted their price objective on shares of Allstate from $209.00 to $230.00 and gave the stock a "buy" rating in a research report on Friday, November 15th. Finally, Piper Sandler lifted their price objective on shares of Allstate from $206.00 to $244.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Allstate presently has a consensus rating of "Moderate Buy" and an average target price of $217.94.
Read Our Latest Stock Report on Allstate
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.